Dr. Philomena F. McAndrew is a highly respected and experienced hematology and oncology specialist practicing in Beverly Hills, California. With a career spanning over four decades, she is known for her exceptional expertise and compassionate patient care. A graduate of the University of Pennsylvania Perelman School of Medicine, Dr. McAndrew completed her fellowship training at UCLA, and she is affiliated with the renowned Cedars-Sinai Medical Center. Her commitment to the field is evident through her extensive work, which includes research and authored scientific papers on critical topics such as lymphoma, multiple myeloma, and breast cancer. Patients consistently praise her ability to clearly explain complex medical conditions, making them feel informed and empowered in their healthcare journey.
Beyond her clinical practice, Dr. McAndrew has made significant contributions to the medical community, having served as the clinical vice chief of medicine and the chairperson of the Pharmacy and Therapeutics Medication Safety Committee at Cedars-Sinai Medical Center. She is also a dedicated member of several professional organizations, including the American Society of Hematology and the American Society of Clinical Oncology. Her special interest in breast cancer is reflected in her active role as a board member of the Wellness Community and Research for Women’s Cancer. Dr. McAndrew’s long-standing dedication to her profession and her patients has earned her recognition as a “Castle Connolly Top Doctor” for multiple years, solidifying her reputation as a leader in her field.
(310) 888-8680
9090 Wilshire Blvd #300, Beverly Hills, CA, 90211
Dr. Philomena F. McAndrew’s medical education and training are extensive and highly distinguished. She received her medical degree from the University of Pennsylvania Perelman School of Medicine in 1978. Following this, she completed her internship and residency in Internal Medicine at Temple University Hospital.
Dr. McAndrew further specialized her training with a fellowship in Hematology and Oncology at the University of California, Los Angeles (UCLA). After her fellowship, she held a full-time position at the UCLA School of Medicine, where she was involved in patient care, research, and authored scientific papers. She is board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine.